Cellucor Debuts Performance Sports Drink/BCAA, Alpha Amino®, With Chance to Sa... (New York NY (PRWEB) December 27 2013 ...)

Cellucor Debuts Performance Sports Drink/BCAA, Alpha Amino®, With Chance to Save 50% Off

Date:12/27/2013

New York, NY (PRWEB) December 27, 2013

Cellucor has delivered the newest addition to their flagship Chrome Series line, Alpha Amino. After months of build up on the top-selling brand’s Facebook and Twitter pages, the performance sports drink is finally hitting shelves, in store and online, with a huge opportunity to save on the purchase of the product.

"We are so excited to deliver a truly innovative Amino/BCAA product that we're giving customers the chance to get Cellucor for pennies on the dollar," said Cellucor VP, Daniel Lourenco. "Alpha Amino tastes and performs better than anything on the market, and I'm excited for people to be able to try it for up to 50% off with this great introductory promotion."

Cellucor fans can take advantage of this introductory offer by going to AlphaAmino.com. AlphaAmino.com features an in-depth product overview, and prompts users to post to their social accounts to then receive a coupon by email. The coupon is good at Cellucor.com, GNC and Bodybuilding.com.

Alpha Amino is a high performance sports drink that features a premium BCAA blend, highlighted by 3x Leucine™, and 11 additional Amino Acids to promote muscular endurance and recovery. Alpha Amino also features a potent hydration blend that’s naturally powered by Chia Seed and Coconut Water to keep users hydrated on the field, in the weight room or anytime throughout the day.

Cellucor is an award-winning, safe and effective supplement brand known for its premier weight loss and sports nutrition product offerings. Cellucor products can be found at GNC, Bodybuilding.com, Vitamin Shoppe and select retailers internationally. Visit Cellucor.com or connect with the company on Facebook or Twitter.

Read the f
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Cellucor Announces the Upcoming Launch of Alpha Amino
2. The Makers of Cellucor Launch “Royal Sport LTD” Exclusively at GNC Franchise Stores Nationwide
3. Cellucor Set for an Exciting Weekend at Olympia Fitness & Performance Expo
4. Makers of Cellucor to Attend 2013 Olympia Fitness & Performance Expo; Will Unveil New Brand, Neon Sport
5. Cellucor Giving Fans a Chance to Win $100 Worth of Products via BoomFit’s 'BCS Games' CrossFit Facebook Page
6. Cellucor Kicks Off the P6 Blitz with Contests and Giveaways All September Long
7. Team Cellucor Athlete Wins 2nd Place for WBFF Pro Diva Fitness Competition
8. Cellucor to Attend Europa Get Fit & Sports Expo in Dallas, Texas
9. Bodybuilding.com Debuts Cellucor’s Electrifying New Supplement Brand, ‘Neon Sport’
10. Cellucor to Perform Product Training for Vitamin Shoppe Retail Team at this Week’s Vitamin Shoppe Product Training Expo
11. Cellucor Sponsors Fourth Annual 'BCS CrossFit' Event

Post Your Comments:

(Date:7/27/2014)... University scientists have shown that a powerful drug given ... only halves the early risk of rejection, but that ... drugs to be used after the operation. , The ... and presented at the World Transplant Congress in San ... difficult transplant conundrum: the powerful combinations of treatments used ...

(Date:7/27/2014)... July 27, 2014 According to a ... Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) ... Forecast, 2013-2019" the global endoscopy devices market was valued ... to grow at a CAGR of 6.8% from 2013 ... 36.9 billion in 2019. , Endoscopy procedures are performed ...

(Date:7/27/2014)... constant expansion of companies across the globe has led ... factors that have increased this demand include the application ... learning and development, security and safety, and knowledge sharing ... video market value has crossed $11.21 billion in 2013 ... with a compound annual growth rate (CAGR) of 25.97%. ...

(Date:7/27/2014)... July 27, 2014 The North American ... estimated at $1570 million in 2014, and it is ... CAGR of 4.64%. The report incorporates the factors that ... expectations of growth rates and projected total expenditure. The ... the global markets. Apart from the general overview of ...

(Date:7/27/2014)... (Sunday July 27 11:45 am ET): A ... the surgical sitehas been reduced by 77 percent ... the American College of Surgeons National Surgical Quality ... case study presented at the 2014 ACS NSQIP ... Columbia, reportedly reduced its rate of cardiac surgical ...

Breaking Medicine News(10 mins):Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 2 Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 3 Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2 Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3 Health News:Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4 Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 2 Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 3 Health News:North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor 4 Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 2 Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 3 Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 4 Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 5 Health News:Surgical safety program greatly reduces surgical site infections for heart operations 2 Health News:Surgical safety program greatly reduces surgical site infections for heart operations 3 Health News:Surgical safety program greatly reduces surgical site infections for heart operations 4

[0] Kidney transplant drug halves the early risk of rejection and allows less toxic treatment [0] Global Endoscopy Devices Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 [0] North America Enterprise Video Market is Expected to Reach $13.00 billion in 2018 - New Report by MicroMarket Monitor [0] North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor [0] Surgical safety program greatly reduces surgical site infections for heart operations

... , PALO ALTO, Calif., Aug. 10 ... will report its second quarter 2009 financial results on Tuesday, August 11, ... to discuss the results, provide guidance for 2009, and give a company ... Time. , , The live webcast and press release ...

... Aug. 10 VION PHARMACEUTICALS, INC. (OTC Bulletin ... Oncologic Drugs Advisory Committee (ODAC) Meeting at which its lead ... , , The ODAC reviews and evaluates ... human drug products for use in the treatment of cancer ...

... 10, 2009 UT Southwestern Medical Center researchers are ... track down and kill cancer cells in patients with ... Researchers are testing a tumor-specific protein called recombinant ... interact with the body,s immune system and generate a ...

... - Researchers from Indiana University,s Center for Health Policy ... government-sponsored health insurance for individuals under age 65 remains ... described or how involved the government would be. ... a government-sponsored health insurance option, such as that being ...

... help contribute to obesity among its users, according to a ... Researchers found that the average user of food stamps had ... The link between food stamps and higher weight was almost ... BMI than those not in the program, the study found. ...

... of all human cancer tumors, the Ras protein literally "drives ... Faculty of Life Sciences at Tel Aviv University. Prof. Kloog ... anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, ... Journal of Pharmacology shows that the drug might be able ...

Cached Medicine News:Health News:Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM) 2 Health News:Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM) 3 Health News:UT Southwestern researchers launch study into search-and-destroy antigen for deadly skin cancer 2 Health News:Americans remain divided on government involvement in health insurance, IU survey shows 2 Health News:Americans remain divided on government involvement in health insurance, IU survey shows 3 Health News:Food stamp use linked to weight gain, study finds 2 Health News:Food stamp use linked to weight gain, study finds 3 Health News:Taking the needle's sting out of diabetes 2

Jazz Pharmaceuticals to Announce Second Quarter Financial Results on August 11, 2009 Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)UT Southwestern researchers launch study into search-and-destroy antigen for deadly skin cancer Americans remain divided on government involvement in health insurance, IU survey shows Food stamp use linked to weight gain, study finds Taking the needle's sting out of diabetes

(Date:7/24/2014)... , July 24, 2014 Parnell Pharmaceuticals ... compounds that will be added to Parnell,s already ... CIMTECH Pty Ltd, a biotechnology company. The compounds ... have shown promise in bone regeneration and dermal ... develop the compounds for the veterinary market with ...

(Date:7/24/2014)... July 24, 2014 Restore Health, a leading ... pharmaceuticals, announced that it is now offering pharmacogenetics ... each individual based upon their particular genetic makeup. ... the interaction between a patient,s genetics and their ... excited to provide this new service to healthcare ...

(Date:7/24/2014)... HILDEN , Germany , and ... , Exclusive global ... assays for SF3B1 mutations, including next-generation sequencing (NGS) gene ... gene, to be targeted by new test, indicate favorable ... myelodysplastic syndromes QIAGEN sees potential for developing ...

Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2 Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3 Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4 Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2 Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3 QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2 QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3 QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4 QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5

[0] Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration [0] Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services [0] QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline

... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...

... 3 Reportlinker.com announces that a new ... catalogue. , Wheelchair Market Shares, ... , http://www.reportlinker.com/p0157387/Wheelchair-Market-Shares-Strategies-and-Forecasts-Worldwide-2009-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire ... This 2009 study has 484 pages, 235 ...

Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy Reportlinker Adds Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2009 to 2015

Inquire...

Medicine Products:

RC-120GX Optima TLX RC12BP J6-HC